Gamal Ghoniem1, Jessica Hammett2. 1. Department of Urology, Division of Female Urology, Pelvic Reconstruction Surgery and Voiding Dysfunction, University of California, Irvine 333 City Blvd. West, Ste 2100, Orange, CA, 92868, USA. gghoniem@uci.edu. 2. Department of Urology, Division of Female Urology, Pelvic Reconstruction Surgery and Voiding Dysfunction, University of California, Irvine 333 City Blvd. West, Ste 2100, Orange, CA, 92868, USA.
Abstract
INTRODUCTION AND HYPOTHESIS: The purpose of this study is to describe the current practice patterns of the International Urogynecological Association (IUGA) members regarding the diagnosis, evaluation, and surgical management of stress urinary incontinence (SUI) and pelvic organ prolapse (POP). METHODS: A 30-item internet-based survey was sent to IUGA members. Response to the survey was voluntary, and subjects answered questions regarding demographics, the evaluation of POP and SUI, including urodynamics (UDS) testing, preferred management of POP and SUI, and the application of mesh in reconstructive surgery. RESULTS: Three hundred and thirty-four IUGA members responded to the survey; most of the responses were from Europe (40 %) and North America (23 %). After the FDA safety communication regarding serious complications of using transvaginal mesh, 45 % of responders reported decreased use of mesh, while 31 % reported that it had no effect or that they did not use mesh for transvaginal prolapse (23.6 %). Regarding the evaluation and treatment of SUI, 51 % of responders would perform urodynamics (UDS) before surgical correction of uncomplicated SUI and 78.5 % of responders would perform UDS if no urine leakage was demonstrated on examination. The preferred method of treatment for SUI is midurethral sling (MUS), regardless of prior treatments (65.1 %), concomitant surgeries (74.5 %), or examination findings (50.8-92.6 %). Regarding POP repair, the preferred approach for apical (61 %) and posterior (99.4 %) prolapse repair is vaginal. CONCLUSIONS: Most respondents use a vaginal approach for POP surgery. The FDA safety communication regarding serious complications related to the use of transvaginal mesh for prolapse surgery led to a global decrease in the employment of mesh for POP. Synthetic midurethral slings are predominant in the current treatment of SUI. Despite new recommendations, many responders still perform UDS for uncomplicated SUI.
INTRODUCTION AND HYPOTHESIS: The purpose of this study is to describe the current practice patterns of the International Urogynecological Association (IUGA) members regarding the diagnosis, evaluation, and surgical management of stress urinary incontinence (SUI) and pelvic organ prolapse (POP). METHODS: A 30-item internet-based survey was sent to IUGA members. Response to the survey was voluntary, and subjects answered questions regarding demographics, the evaluation of POP and SUI, including urodynamics (UDS) testing, preferred management of POP and SUI, and the application of mesh in reconstructive surgery. RESULTS: Three hundred and thirty-four IUGA members responded to the survey; most of the responses were from Europe (40 %) and North America (23 %). After the FDA safety communication regarding serious complications of using transvaginal mesh, 45 % of responders reported decreased use of mesh, while 31 % reported that it had no effect or that they did not use mesh for transvaginal prolapse (23.6 %). Regarding the evaluation and treatment of SUI, 51 % of responders would perform urodynamics (UDS) before surgical correction of uncomplicated SUI and 78.5 % of responders would perform UDS if no urine leakage was demonstrated on examination. The preferred method of treatment for SUI is midurethral sling (MUS), regardless of prior treatments (65.1 %), concomitant surgeries (74.5 %), or examination findings (50.8-92.6 %). Regarding POP repair, the preferred approach for apical (61 %) and posterior (99.4 %) prolapse repair is vaginal. CONCLUSIONS: Most respondents use a vaginal approach for POP surgery. The FDA safety communication regarding serious complications related to the use of transvaginal mesh for prolapse surgery led to a global decrease in the employment of mesh for POP. Synthetic midurethral slings are predominant in the current treatment of SUI. Despite new recommendations, many responders still perform UDS for uncomplicated SUI.
Entities:
Keywords:
IUGA; Pelvic organ prolapse; Practice patterns; Stress urinary incontinence; Survey
Authors: Lore Schierlitz; Peter L Dwyer; Anna Rosamilia; Christine Murray; Elizabeth Thomas; Alison De Souza; Richard Hiscock Journal: Obstet Gynecol Date: 2012-02 Impact factor: 7.661
Authors: Holly E Richter; Michael E Albo; Halina M Zyczynski; Kimberly Kenton; Peggy A Norton; Larry T Sirls; Stephen R Kraus; Toby C Chai; Gary E Lemack; Kimberly J Dandreo; R Edward Varner; Shawn Menefee; Chiara Ghetti; Linda Brubaker; Ingrid Nygaard; Salil Khandwala; Thomas A Rozanski; Harry Johnson; Joseph Schaffer; Anne M Stoddard; Robert L Holley; Charles W Nager; Pamela Moalli; Elizabeth Mueller; Amy M Arisco; Marlene Corton; Sharon Tennstedt; T Debuene Chang; E Ann Gormley; Heather J Litman Journal: N Engl J Med Date: 2010-05-17 Impact factor: 91.245
Authors: Charles W Nager; Linda Brubaker; Heather J Litman; Halina M Zyczynski; R Edward Varner; Cindy Amundsen; Larry T Sirls; Peggy A Norton; Amy M Arisco; Toby C Chai; Philippe Zimmern; Matthew D Barber; Kimberly J Dandreo; Shawn A Menefee; Kimberly Kenton; Jerry Lowder; Holly E Richter; Salil Khandwala; Ingrid Nygaard; Stephen R Kraus; Harry W Johnson; Gary E Lemack; Marina Mihova; Michael E Albo; Elizabeth Mueller; Gary Sutkin; Tracey S Wilson; Yvonne Hsu; Thomas A Rozanski; Leslie M Rickey; David Rahn; Sharon Tennstedt; John W Kusek; E Ann Gormley Journal: N Engl J Med Date: 2012-05-02 Impact factor: 91.245
Authors: J Christian Winters; Roger R Dmochowski; Howard B Goldman; C D Anthony Herndon; Kathleen C Kobashi; Stephen R Kraus; Gary E Lemack; Victor W Nitti; Eric S Rovner; Alan J Wein Journal: J Urol Date: 2012-10-24 Impact factor: 7.450
Authors: Emily A Slopnick; Andrey Petrikovets; David Sheyn; Simon P Kim; Carvell T Nguyen; Adonis K Hijaz Journal: Int Urogynecol J Date: 2018-10-03 Impact factor: 2.894